Two Sigma Investments, LP Maxcyte, Inc. Transaction History

Two Sigma Investments, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.63 - $5.0 $228,486 - $314,720	-62,944 Reduced 72.89%	23,406 $91,000
Q1 2024 May 15, 2024	SELL	$3.94 - $5.38 $260,079 - $355,133	-66,010 Reduced 43.33%	86,350 $361,000
Q4 2023 Feb 14, 2024	BUY	$2.6 - $5.24 $396,136 - $798,366	152,360 New	152,360 $716,000
Q2 2023 Aug 14, 2023	BUY	$3.69 - $5.35 $57,789 - $83,786	15,661 New	15,661 $71,000
Q2 2022 Aug 15, 2022	BUY	$3.59 - $6.81 $95,461 - $181,084	26,591 Added 89.52%	56,294 $266,000
Q1 2022 May 16, 2022	BUY	$5.26 - $10.84 $38,966 - $80,302	7,408 Added 33.23%	29,703 $208,000
Q4 2021 Feb 14, 2022	BUY	$8.87 - $12.94 $94,483 - $137,836	10,652 Added 91.49%	22,295 $227,000
Q3 2021 Nov 15, 2021	BUY	$12.21 - $17.2 $142,161 - $200,259	11,643 New	11,643 $142,000

124

65.6M

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $426M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.